← Back
Data updated: Mar 10, 2026
LEGACY PHARMA
RespiratoryGastroenterologyImmunology
LEGACY PHARMA is a major pharmaceutical company focused on Respiratory, Gastroenterology, Immunology. Key products include BRISDELLE.
1968
Since
15
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
Recent Activity
BRISDELLE 2025-02-11
Labeling
BRISDELLE 2025-02-11
Labeling
IMURAN 2024-07-09
Labeling
IMURAN 2024-07-09
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 25%
1 drugs
Gastroenterology 25%
1 drugs
Immunology 25%
1 drugs
Cardiovascular 25%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
BAUSCH specialty
Immunology, Cardiovascular, Gastroenterology
AstraZeneca big-pharma
Respiratory, Cardiovascular, Immunology
COREPHARMA other
Cardiovascular, Respiratory, Immunology, Gastroenterology
Boehringer Ingelheim big-pharma
Respiratory, Immunology, Cardiovascular